February 5, 2014
Discovery may pave way for RSV vaccine
Vanderbilt University scientists have contributed to a major finding, reported this week in the journal Nature, which could lead to the first effective vaccine against respiratory syncytial virus (RSV), a significant cause of infant mortality.
By Bill Snyder